spacer
spacer

PDBsum entry 6c0h

Go to PDB code: 
protein metals Protein-protein interface(s) links
Biosynthetic protein PDB id
6c0h

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
114 a.a.
108 a.a.
14 a.a.
Metals
__K ×2
Waters ×143
PDB id:
6c0h
Name: Biosynthetic protein
Title: Lysinoalanine synthase, durn, from duramycin biosynthesis bound to 1- dha6ala
Structure: Lysinoalanine synthase. Chain: a, b. Engineered: yes. Gln-dal-cys-ala-phe-gly-pro-phe-dbb-phe-val-cys-bh2-gly. Chain: c. Engineered: yes
Source: Streptomyces cinnamoneus. Organism_taxid: 53446. Atcc: 12686. Gene: durn. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Gene: dura.
Resolution:
1.90Å     R-factor:   0.194     R-free:   0.251
Authors: D.P.Cogan,S.K.Nair
Key ref: L.An et al. (2018). Substrate-assisted enzymatic formation of lysinoalanine in duramycin. Nat Chem Biol, 14, 928-933. PubMed id: 30177849 DOI: 10.1038/s41589-018-0122-4
Date:
31-Dec-17     Release date:   05-Sep-18    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
A0A3F2YLX1  (A0A3F2YLX1_STRCJ) -  Lysinoalanine synthase from Streptomyces cinnamoneus
Seq:
Struc:
121 a.a.
114 a.a.
Protein chain
Pfam   ArchSchema ?
A0A3F2YLX1  (A0A3F2YLX1_STRCJ) -  Lysinoalanine synthase from Streptomyces cinnamoneus
Seq:
Struc:
121 a.a.
108 a.a.
Protein chain
Pfam   ArchSchema ?
A0A3F2YLX0  (A0A3F2YLX0_STRCJ) -  Gln-dal-cys-ala-phe-gly-pro-phe-dbb-phe-val-cys-bh2-gly from Streptomyces cinnamoneus
Seq:
Struc:
22 a.a.
14 a.a.*
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 3 residue positions (black crosses)

 

 
DOI no: 10.1038/s41589-018-0122-4 Nat Chem Biol 14:928-933 (2018)
PubMed id: 30177849  
 
 
Substrate-assisted enzymatic formation of lysinoalanine in duramycin.
L.An, D.P.Cogan, C.D.Navo, G.Jiménez-Osés, S.K.Nair, W.A.van der Donk.
 
  ABSTRACT  
 
Duramycin is a heavily post-translationally modified peptide that binds phosphatidylethanolamine. It has been investigated as an antibiotic, an inhibitor of viral entry, a therapeutic for cystic fibrosis, and a tumor and vasculature imaging agent. Duramycin contains a β-hydroxylated Asp (Hya) and four macrocycles, including an essential lysinoalanine (Lal) cross-link. The mechanism of Lal formation is not known. Here we show that Lal is installed stereospecifically by DurN via addition of Lys19 to a dehydroalanine. The structure of DurN reveals an unusual dimer with a new fold. Surprisingly, in the structure of duramycin bound to DurN, no residues of the enzyme are near the Lal cross-link. Instead, Hya15 of the substrate makes interactions with Lal, suggesting it acts as a base to deprotonate Lys19 during catalysis. Biochemical data suggest that DurN preorganizes the reactive conformation of the substrate, such that the Hya15 of the substrate can serve as the catalytic base for Lal formation.
 

 

spacer

spacer